Commentary Volume 3, Issue 1 pp 14—16
Treating transgenic Alzheimer mice with a β-secretase inhibitor, what have we learned?
- 1 Protein Studies Program, Oklahoma Medical Research Foundation, University of Oklahoma Health Science Center, Oklahoma City, Oklahoma, USA
- 2 Departments of Chemistry and Medicinal Chemistry, Purdue University, West Lafayette, Indiana, USA
Received: January 12, 2011 Published: January 17, 2011https://doi.org/10.18632/aging.100267
How to Cite